4.25
price down icon0.93%   -0.04
pre-market  Vorhandelsmarkt:  4.32   0.07   +1.65%
loading

Finanzdaten der Unicycive Therapeutics Inc-Aktie (UNCY)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
12.84%
6.963
7.989 9.261 6.251 7.401
Operating Income/Loss
12.84%
-6.963
-7.989 -9.261 -6.251 -7.401
Nonoperating Income/Loss
93.97%
0.516
8.559 -12.26 2.155 17.26
Income/Loss From Continuing Operations Before Tax
1,231%
-6.447
0.57 -21.52 -4.096 9.855
Income/Loss From Continuing Operations After Tax
1,231%
-6.447
0.57 -21.52 -4.096 9.855
Net Income/Loss
1,231%
-6.447
0.57 -21.52 -4.096 9.855
Preferred Stock Dividends And Other Adjustments
-
- - - 0.887
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
89.47%
12.30
116.82 12.91 88.94 37.91
Diluted Average Shares
90.07%
12.30
123.83 12.91 88.94 94.05
Basic Earnings Per Share
1,833%
-0.52
0.03 -0.26 -0.05 0.08
Diluted Earnings Per Share
940.00%
-0.52
-0.05 -0.26 -0.05 -0.15
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$24.54
price up icon 0.95%
$84.00
price down icon 0.90%
$26.98
price up icon 2.70%
$104.79
price down icon 0.27%
$132.17
price up icon 3.00%
biotechnology ONC
$308.91
price up icon 0.09%
Kapitalisierung:     |  Volumen (24h):